New guideline set for clinical trial GMP

The Korea Food and Drug Administration said that it has recently set up a new guideline about procedures and obligations for the manufacture and quality control of drugs to be used in clinical trials, as part of its effort to establish the safety and efficacy of clinical drugs as well as reliability of clinical drugs.

Under the new guideline, obligatory validation tests including adoptabilit...